The growth of endoscopic retrograde
cholangiopancreatography market is majorly
attributed to factors such as the rising incidence of cancer, increasing
investments by governments and healthcare organizations to improve endoscopy
research, growing focus on investments by hospitals for advanced endoscopy
instruments, and the increasing preference for minimally invasive surgeries.
The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period.
Key players in the ERCP
market include Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm
Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co.
KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson
& Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B. Braun
Melsungen AG (Germany).
Olympus Corporation
(Japan): Olympus is a leading
player in the endoscopic retrograde cholangiopancreatography market. The
company uses alliances and acquisitions to get a strong ERCP market. For
instance, in January 2021, the company entered a five-year contract to jointly
develop endoscopic ultrasound systems (EUS) with Hitachi Ltd. (Japan).
Similarly, in January 2021, the company acquired Quest Innovations B.V.
(Netherlands), which enabled Olympus to strengthen its surgical endoscopy
capabilities and incorporate Quest’s advanced FIS capabilities into its
comprehensive medical imaging portfolio. The company operates in around 40
countries across the Americas, Africa, Eastern Europe, the Middle East, Asia,
and Oceania.
Fujifilm Holdings
Corporation (Japan): Fujifilm is
one of the key players in the endoscopic retrograde cholangiopancreatography
market. The company uses product launches, acquisitions, and partnerships to
strengthen its position in the market. For instance, in July 2020, Fujifilm
launched ELUXEO Surgical Visualization System, which enables surgeons to
visualize while performing both flexible and rigid endoscopy from a single
tower. Additionally, in March 2021, the company acquired Hitachi, Ltd.’s
Diagnostic Imaging-related Business (Japan), which enabled Fujifilm to expand
its Healthcare business further. The company has a vast geographic reach across
North America, Latin America, Europe, Asia Pacific, and the Middle East &
Africa.
HOYA Corporation (Japan): HOYA Corporation is one of the leading players in the ERCP Market. The company resorts to product launches, acquisitions, and joint ventures to hold its position in the market. For instance, in May 2021, PENTAX Medical (Japan), a subsidiary of HOYA Corporation, entered a joint venture with Vedkang Medical Science and Technology Co., Ltd. (China) to develop single-use therapeutic products in the field of flexible medical endoscopy. In addition, in May 2021, the company launched PENTAX Medical ONE Pulmo Bronchoscope. The company has a widespread presence worldwide, spanning North America, Europe, Asia, and Oceania.
Boston Scientific
Corporation: Boston
Scientific Corporation develops, manufactures, and markets medical devices for
several interventional medical specialties (including endoscopy). The company
has a strong geographic presence in the US, the Asia Pacific, and other main
markets in Europe. Bostin Scientific’s products are distributed worldwide
through customer service centers in the US, the Netherlands, and Japan. There
was a steady growth in the R&D expenditure from USD 920 million in 2016 to
USD 1,143 million in 2020.